Gastroenterology Department, Virgen de La Luz Hospital, Av. Hermandad de Donantes de Sangre, 1, 16002, Cuenca, Spain.
Medical Analysis Expert Group, Institute of Technology, Universidad de Castilla-La Mancha, Cuenca, Spain.
Dig Dis Sci. 2023 Sep;68(9):3801-3809. doi: 10.1007/s10620-023-08031-y. Epub 2023 Jul 21.
Nonalcoholic fatty liver disease (NAFLD) is a silent epidemy that has become the most common chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH) is an advanced stage of NAFLD, which is linked to a high risk of cirrhosis and hepatocellular carcinoma. The aim of this study is to develop a predictive model to identify the main risk factors associated with the progression of hepatic fibrosis in patients with NASH.
A database from a multicenter retrospective cross-sectional study was analyzed. A total of 215 patients with NASH biopsy-proven diagnosed were collected. NAFLD Activity Score and Kleiner scoring system were used to diagnose and staging these patients. Noninvasive tests (NITs) scores were added to identify which one were more reliable for follow-up and to avoid biopsy. For analysis, different Machine Learning methods were implemented, being the eXtreme Gradient Booster (XGB) system the proposed algorithm to develop the predictive model.
The most important variable in this predictive model was High-density lipoprotein (HDL) cholesterol, followed by systemic arterial hypertension and triglycerides (TG). NAFLD Fibrosis Score (NFS) was the most reliable NIT. As for the proposed method, XGB obtained higher results than the second method, K-Nearest Neighbors, in terms of accuracy (95.05 vs. 90.42) and Area Under the Curve (0.95 vs. 0.91).
HDL cholesterol, systemic arterial hypertension, and TG were the most important risk factors for liver fibrosis progression in NASH patients. NFS is recommended for monitoring and decision making.
非酒精性脂肪性肝病(NAFLD)是一种无声的流行疾病,已成为全球最常见的慢性肝病。非酒精性脂肪性肝炎(NASH)是 NAFLD 的一个晚期阶段,与肝硬化和肝细胞癌的高风险相关。本研究旨在开发一种预测模型,以确定与 NASH 患者肝纤维化进展相关的主要危险因素。
分析了一项多中心回顾性横断面研究的数据库。共收集了 215 例经肝活检证实的 NASH 患者。采用 NAFLD 活动评分和 Kleiner 评分系统对这些患者进行诊断和分期。加入无创检测(NIT)评分,以确定哪些评分更适合用于随访和避免活检。为此分析采用了不同的机器学习方法,其中极端梯度提升(XGB)系统是提出的开发预测模型的算法。
在这个预测模型中最重要的变量是高密度脂蛋白(HDL)胆固醇,其次是系统性动脉高血压和甘油三酯(TG)。NAFLD 纤维化评分(NFS)是最可靠的 NIT。就所提出的方法而言,XGB 在准确性(95.05%对 90.42%)和曲线下面积(0.95 对 0.91)方面优于第二种方法 K-最近邻。
HDL 胆固醇、系统性动脉高血压和 TG 是非酒精性脂肪性肝炎患者肝纤维化进展的最重要危险因素。建议使用 NFS 进行监测和决策。